Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study

Detalles Bibliográficos
Autores principales: Schett, Georg, Chen, Warner, Gao, Sheng, Chakravarty, Soumya D., Shawi, May, Lavie, Frederic, Zimmermann, Miriam, Sharaf, Mohamed, Coates, Laura C., Siebert, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503169/
https://www.ncbi.nlm.nih.gov/pubmed/37715280
http://dx.doi.org/10.1186/s13075-023-03158-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503169/
https://www.ncbi.nlm.nih.gov/pubmed/37715280
http://dx.doi.org/10.1186/s13075-023-03158-9

Ejemplares similares